Search research articles
Contact Us
Filters
Showing results (21-30 of 57) with videos related to
Page
of 6
Sort By:
European Urology
|
July 26, 2005
The 5alpha-reductase type II A49T and V89L high-activity allelic variants are more common in men with prostate cancer compared with the general population
Yvonne L Giwercman, Per-Anders Abrahamsson, Aleksander Giwercman, et al.
BJU International
|
January 18, 2014
Is intermittent androgen-deprivation therapy beneficial for patients with advanced prostate cancer?
Johannes M Wolff, Per-Anders Abrahamsson, Jacques Irani, et al.
European Urology
|
December 7, 2007
The characterization of epithelial and stromal subsets of candidate stem/progenitor cells in the human adult prostate
Jens A Ceder, Linda Jansson, Roy A Ehrnström, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
July 17, 2010
Properties and effects of a novel liquid crystal nanoparticle formulation of docetaxel in a prostate cancer mouse model
Camilla Cervin, Martina Tinzl, Markus Johnsson, et al.
Scandinavian Journal of Urology and Nephrology
|
October 22, 2010
PCA3 as a diagnostic marker for prostate cancer: a validation study on a Swedish patient population
Martin Nyberg, David Ulmert, Anna Lindgren, et al.
The Prostate
|
June 15, 2011
Regional distribution of neuroendocrine cells in the urogenital duct system of the male rat
Gerhard Aumüller, Andreas Doll, Gunther Wennemuth, et al.
Plos One
|
November 22, 2013
Interaction between c-jun and androgen receptor determines the outcome of taxane therapy in castration resistant prostate cancer
Martina Tinzl, Binshen Chen, Shao-Yong Chen, et al.
Plos One
|
December 19, 2018
Correction: Interaction between c-jun and Androgen Receptor Determines the Outcome of Taxane Therapy in Castration Resistant Prostate Cancer
Martina Tinzl, Binshen Chen, Shao-Yong Chen, et al.
The Prostate
|
March 26, 2004
Androgen receptor CAG repeat length correlates with semen PSA levels in adolescence
Yvonne Lundberg Giwercman, Jonas Richthoff, Hans Lilja, et al.
Urologic Oncology
|
November 21, 2009
Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines
Nishtman Dizeyi, Petter Hedlund, Anders Bjartell, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 57) with videos related to
Sort By:
Page
of 6
European Urology
|
July 26, 2005
The 5alpha-reductase type II A49T and V89L high-activity allelic variants are more common in men with prostate cancer compared with the general population
Yvonne L Giwercman, Per-Anders Abrahamsson, Aleksander Giwercman, et al.
BJU International
|
January 18, 2014
Is intermittent androgen-deprivation therapy beneficial for patients with advanced prostate cancer?
Johannes M Wolff, Per-Anders Abrahamsson, Jacques Irani, et al.
European Urology
|
December 7, 2007
The characterization of epithelial and stromal subsets of candidate stem/progenitor cells in the human adult prostate
Jens A Ceder, Linda Jansson, Roy A Ehrnström, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
July 17, 2010
Properties and effects of a novel liquid crystal nanoparticle formulation of docetaxel in a prostate cancer mouse model
Camilla Cervin, Martina Tinzl, Markus Johnsson, et al.
Scandinavian Journal of Urology and Nephrology
|
October 22, 2010
PCA3 as a diagnostic marker for prostate cancer: a validation study on a Swedish patient population
Martin Nyberg, David Ulmert, Anna Lindgren, et al.
The Prostate
|
June 15, 2011
Regional distribution of neuroendocrine cells in the urogenital duct system of the male rat
Gerhard Aumüller, Andreas Doll, Gunther Wennemuth, et al.
Plos One
|
November 22, 2013
Interaction between c-jun and androgen receptor determines the outcome of taxane therapy in castration resistant prostate cancer
Martina Tinzl, Binshen Chen, Shao-Yong Chen, et al.
Plos One
|
December 19, 2018
Correction: Interaction between c-jun and Androgen Receptor Determines the Outcome of Taxane Therapy in Castration Resistant Prostate Cancer
Martina Tinzl, Binshen Chen, Shao-Yong Chen, et al.
The Prostate
|
March 26, 2004
Androgen receptor CAG repeat length correlates with semen PSA levels in adolescence
Yvonne Lundberg Giwercman, Jonas Richthoff, Hans Lilja, et al.
Urologic Oncology
|
November 21, 2009
Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines
Nishtman Dizeyi, Petter Hedlund, Anders Bjartell, et al.
Page
of 6